Boothbay Fund Management’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

Boothbay Fund Management’s Portfolio BIOS Stock Details BIOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-783,734	Closed	-$8.18M	–	2506
2023 Q1	$8.18M	Buy	783,734 +762,988	+3,678%	+$7.9M	0.17%	113
2022 Q4	$213K	Hold	20,746	–	–	﹤0.01%	1580
2022 Q3	$208K	Buy	20,746 +13	+0.1%	+$130	0.01%	1822
2022 Q2	$208K	Hold	20,733	–	–	0.01%	1720
2022 Q1	$205K	Buy	+20,733	New	+$205K	﹤0.01%	1869

Other funds holding BIOS

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return

MSU

Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return

WRBC

W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Quarry LP New York $1.2B AUM 47.63% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Boothbay Fund Management's BIOS Position: Q2 2023 in Review

Boothbay Fund Management sold out of BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) in Q2 2023, closing a stake of 783,734 shares — an estimated $8.18M sold.

Boothbay Fund Management first reported a position in BIOS in Q1 2022 and held it in 5 quarters. The position peaked at $8.18M in Q1 2023. 32 funds tracked by Wall St. Rank hold BIOS as of Q2 2023.

Boothbay Fund Management reported no remaining BioPlus Acquisition Corp. Class A Ordinary Shares position as of Q2 2023 after selling out during the quarter.
Boothbay Fund Management sold 783,734 BioPlus Acquisition Corp. Class A Ordinary Shares shares in Q2 2023, an estimated $8.18M.
Boothbay Fund Management first reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares in Q1 2022 and held it in 5 quarters.
Boothbay Fund Management's BioPlus Acquisition Corp. Class A Ordinary Shares position peaked at $8.18M in Q1 2023.
32 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Class A Ordinary Shares as of Q2 2023.

Based on Boothbay Fund Management's 13F filing for Q2 2023, filed 14 Aug 2023.